1. Home
  2. ESPR vs BZH Comparison

ESPR vs BZH Comparison

Compare ESPR & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

660.1M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$22.50

Market Cap

717.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
BZH
Founded
2008
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
660.1M
717.3M
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
ESPR
BZH
Price
$3.70
$22.50
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$6.86
$32.00
AVG Volume (30 Days)
7.0M
477.9K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.52
Revenue
$303,802,000.00
$2,371,555,000.00
Revenue This Year
$25.45
$7.40
Revenue Next Year
N/A
$12.09
P/E Ratio
N/A
$14.80
Revenue Growth
2.83
1.77
52 Week Low
$0.69
$17.37
52 Week High
$4.03
$34.39

Technical Indicators

Market Signals
Indicator
ESPR
BZH
Relative Strength Index (RSI) 63.61 50.83
Support Level $3.59 $22.43
Resistance Level $3.91 $23.85
Average True Range (ATR) 0.24 0.90
MACD 0.05 0.25
Stochastic Oscillator 77.74 69.00

Price Performance

Historical Comparison
ESPR
BZH

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: